134 related articles for article (PubMed ID: 29104896)
1. Non-radioactive LATS
Hong AW; Guan KL
Bio Protoc; 2017 Jul; 7(14):. PubMed ID: 29104896
[TBL] [Abstract][Full Text] [Related]
2. Arhgef7 promotes activation of the Hippo pathway core kinase Lats.
Heidary Arash E; Song KM; Song S; Shiban A; Attisano L
EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
[TBL] [Abstract][Full Text] [Related]
4. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
Hao Y; Chun A; Cheung K; Rashidi B; Yang X
J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
[TBL] [Abstract][Full Text] [Related]
6. The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes.
Wennmann DO; Vollenbröker B; Eckart AK; Bonse J; Erdmann F; Wolters DA; Schenk LK; Schulze U; Kremerskothen J; Weide T; Pavenstädt H
Cell Death Dis; 2014 Nov; 5(11):e1519. PubMed ID: 25393475
[TBL] [Abstract][Full Text] [Related]
7. cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes.
Kim M; Kim M; Lee S; Kuninaka S; Saya H; Lee H; Lee S; Lim DS
EMBO J; 2013 May; 32(11):1543-55. PubMed ID: 23644383
[TBL] [Abstract][Full Text] [Related]
8. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1.
Fan R; Kim NG; Gumbiner BM
Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2569-74. PubMed ID: 23359693
[TBL] [Abstract][Full Text] [Related]
10. Deregulation of Hippo kinase signalling in human hepatic malignancies.
Li H; Wolfe A; Septer S; Edwards G; Zhong X; Abdulkarim AB; Ranganathan S; Apte U
Liver Int; 2012 Jan; 32(1):38-47. PubMed ID: 22098159
[TBL] [Abstract][Full Text] [Related]
11. Identification of the kinase STK25 as an upstream activator of LATS signaling.
Lim S; Hermance N; Mudianto T; Mustaly HM; Mauricio IPM; Vittoria MA; Quinton RJ; Howell BW; Cornils H; Manning AL; Ganem NJ
Nat Commun; 2019 Apr; 10(1):1547. PubMed ID: 30948712
[TBL] [Abstract][Full Text] [Related]
12. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H
J Biol Chem; 2021; 296():100400. PubMed ID: 33571521
[TBL] [Abstract][Full Text] [Related]
13. Multi-scale modeling of hippo signaling identifies homeostatic control by YAP-LATS negative feedback.
Sun T
Biosystems; 2021 Oct; 208():104475. PubMed ID: 34237349
[TBL] [Abstract][Full Text] [Related]
14.
Kim E; Kang JG; Kang MJ; Park JH; Kim YJ; Kweon TH; Lee HW; Jho EH; Lee YH; Kim SI; Yi EC; Park HW; Yang WH; Cho JW
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14259-14269. PubMed ID: 32513743
[TBL] [Abstract][Full Text] [Related]
15. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway.
Mo JS; Meng Z; Kim YC; Park HW; Hansen CG; Kim S; Lim DS; Guan KL
Nat Cell Biol; 2015 Apr; 17(4):500-10. PubMed ID: 25751140
[TBL] [Abstract][Full Text] [Related]
16. Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor.
Azad T; Nouri K; Janse van Rensburg HJ; Hao Y; Yang X
J Vis Exp; 2018 Sep; (139):. PubMed ID: 30272653
[TBL] [Abstract][Full Text] [Related]
17. Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling.
Hergovich A
Cell Biosci; 2013 Aug; 3(1):32. PubMed ID: 23985307
[TBL] [Abstract][Full Text] [Related]
18. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
[TBL] [Abstract][Full Text] [Related]
19. Identification of Cdk1-LATS-Pin1 as a Novel Signaling Axis in Anti-tubulin Drug Response of Cancer Cells.
Yeung B; Khanal P; Mehta V; Trinkle-Mulcahy L; Yang X
Mol Cancer Res; 2018 Jun; 16(6):1035-1045. PubMed ID: 29523761
[TBL] [Abstract][Full Text] [Related]
20. Protein kinases of the Hippo pathway: regulation and substrates.
Avruch J; Zhou D; Fitamant J; Bardeesy N; Mou F; Barrufet LR
Semin Cell Dev Biol; 2012 Sep; 23(7):770-84. PubMed ID: 22898666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
